Herlev and Gentofte Hospital

The trials here

What the 22 trials at this site are about, from their registry records.

Conditions

• Heart failure4 trials
• Lung cancer3 trials
• Prostate cancer3 trials
• Ulcerative colitis3 trials
• Bladder cancer2 trials
• Chronic kidney disease2 trials
• Coronary artery disease2 trials
• Obesity2 trials
• Sarcoma2 trials
• Type 2 diabetes2 trials
• Atrial fibrillation1 trial
• Colorectal cancer1 trial
• and 5 more

Phase

• Phase 36 trials
• Phase 22 trials
• Phase 42 trials
• Phase 11 trial
• Phase 1/21 trial
• Phase 2/31 trial

Status

• Recruiting11 trials
• Completed8 trials
• Active, not recruiting3 trials

Lead sponsor

• Eli Lilly and Company5 trials
• Boehringer Ingelheim3 trials
• Copenhagen University Hospital, Rigshospitalet2 trials
• Herlev and Gentofte Hospital2 trials
• Amgen1 trial
• and 9 more

Running trials

• Recruiting

  Peer-Mentor Support for Vulnerable Patients With Atrial Fibrillation

  NCT07498283· University College Copenhagen· Source

  Contact: Cecilie M L Mielow, MScN

• Recruiting

  LY4268989 (MORF-057) Co-Administered with Mirikizumab in Adults with Moderately to Severely Active Ulcerative Colitis: A Phase 2 Study

  2025-522338-30-00· Phase 2· Eli Lilly & Co.· Source

• Recruiting

  Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  NCT07037459· Phase 3· Amgen· Source

• Recruiting

  Chemoablation Or Bladder Resection With Adjuvant Chemotherapy in Recurrent Non-Muscle Invasive Bladder Cancer

  NCT06781879· Phase 4· Jakob Kristian Jakobsen· Source

  Contact: Ann K Bersang, MD

• Recruiting

  Randomized Controlled Trial of the Effects of Combined Resistance and AerobiC Exercise on Health-related Quality of Life in Patients Undergoing First-line Chemotherapy for Metastatic Colorectal Cancer (REACH)

  NCT06938971· Copenhagen University Hospital, Rigshospitalet· Source

  Contact: Louise Lang Lehrskov

• Recruiting

  A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Health Record

  NCT06642272· Phase 4· Herlev and Gentofte Hospital· Source

  Contact: Morten Schou, Professor

• Recruiting

  Cross-sectorial Rehabilitation of Patients with Lung Cancer

  NCT06705465· Camilla Balle· Source

  Contact: Julia S Johansen, Professor

• Active, not recruiting

  The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

  NCT06383390· Phase 3· Eli Lilly and Company· Source

• Recruiting

  High Impact Training to Patients with Prostate Cancer and Bone Metastases

  NCT06259279· Copenhagen University Hospital at Herlev· Source

  Contact: Anne-Mette Ragle, PhD student

• Active, not recruiting

  Risk Factors, Incidence, and Progression of Lymphedema Among Men With Prostate Cancer. The AWARE Cohort

  NCT07607431· Copenhagen University Hospital, Rigshospitalet· Source

• Recruiting

  FRAGINOC Study: Screening and Geriatric Assessment and Intervention in Older Patients With Epithelial Ovarian Cancer

  NCT05810701· Odense University Hospital· Source

  Contact: Jakob Ohm Oreskov, MD

• Active, not recruiting

  Conventionally Fractionated Adaptive Radiation Therapy of Bladder Cancer an Individualized Approach

  NCT05295992· Varian, a Siemens Healthineers Company· Source

• Recruiting

  National Danish Protocol. Surgery+ SBRT for M1 Prostate Cancer Patients

  NCT04086290· Phase 1/2· Peter Busch Østergren· Source

  Contact: Peter B Østergren, MD

• Recruiting

  Copenhagen Baby Heart Study - Impact

  NCT05838079· Henning Bundgaard· Source

  Contact: Kasper Iversen, MD, DMSc

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Heart failure2 recruiting
• Prostate cancer2 recruiting
• Atrial fibrillation1 recruiting
• Bladder cancer1 recruiting
• Chronic kidney disease1 recruiting
• Colorectal cancer1 recruiting
• Congenital heart disease1 recruiting
• Lung cancer1 recruiting
• Obesity1 recruiting
• Ovarian cancer1 recruiting
• Type 2 diabetes1 recruiting
• Ulcerative colitis1 recruiting

Closed trials

• Completed

  The Effect of MediYoga on Sleep Quality, Blood Pressure, and Quality of Life in Older Adults With Hypertension:

  NCT06553820· Herlev and Gentofte Hospital· Source

• Completed

  Brightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma

  NCT05218499· Phase 2/3· Boehringer Ingelheim· Source

• Completed

  EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)

  NCT04509674· Phase 3· Boehringer Ingelheim· Source

• Completed

  A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT03524092· Phase 3· Eli Lilly and Company· Source

• Completed

  An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

  NCT03518086· Phase 3· Eli Lilly and Company· Source

• Completed

  This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancer

  NCT03099174· Phase 1· Boehringer Ingelheim· Source

• Completed

  A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma

  NCT02451943· Phase 3· Eli Lilly and Company· Source

• Completed

  A Study of LY2875358 in Participants With Non-Small Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations

  NCT01897480· Phase 2· Eli Lilly and Company· Source